Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2021 ∙ Mukherjee, P. Akpo, E. I. H. Kuznetsova, A. Knuf, M. Silfverdal, S. A. Kosalaraksa, P. Mihalyi, A.

Hexavalent vaccines in infants: a systematic literature review and meta-analysis of the solicited local and systemic adverse reactions of two hexavalent vaccines

  • Newborn
  • Children
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Knuf, M. Haas, H. Garcia-Corbeira, P. Turriani, E. Mukherjee, P. Janssens, W. Berlaimont, V.

Hexavalent vaccines: What can we learn from head-to-head studies?

  • All age groups
  • Diphtheria
  • Tetanus
  • Pertussis
  • Hepatitis B
  • Poliomyelitis
  • Haemophilus influenzae type B
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Parsons, J. Griffiths, S. E. Thomas, N. Atherton, H.

How effective are digital interventions in increasing flu vaccination among pregnant women? A systematic review and meta-analysis

  • Pregnant women
  • All age groups
  • Influenza
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Poirier, B. Sethi, S. Garvey, G. Hedges, J. Canfell, K. Smith, M. Ju, X. Jamieson, L.

HPV vaccine: uptake and understanding among global Indigenous communities - a qualitative systematic review

  • All age groups
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Dorji, T. Nopsopon, T. Tamang, S. T. Pongpirul, K.

Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis

  • All age groups
  • Low and Middle Income Countries
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Tian, Y. Hua, W. Wu, Y. Zhang, T. Wang, W. Wu, H. Guo, C. Huang, X.

Immune Response to Hepatitis B Virus Vaccine Among People Living With HIV: A Meta-Analysis

  • Adults
  • Older adults
  • Hepatitis B
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Bianchi, F. P. Stefanizzi, P. Spinelli, G. Mascipinto, S. Tafuri, S.

Immunization coverage among asplenic patients and strategies to increase vaccination compliance: a systematic review and meta-analysis

  • All age groups
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Martin, C. Domingo, C. Bottieau, E. Buonfrate, D. De Wit, S. Van Laethem, Y. Dauby, N.

Immunogenicity and duration of protection after yellow fever vaccine in people living with human immunodeficiency virus: a systematic review

  • All age groups
  • Yellow fever
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Schenk, J. Abrams, S. Theeten, H. Van Damme, P. Beutels, P. Hens, N.

Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis

  • All age groups
  • Mumps
  • Measles
  • Rubella
  • Efficacy/effectiveness
  • Coverage
  • Administration
  • Modeling
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Becerril-Gaitan, Andrea Vaca-Cartagena, Bryan F. Ferrigno, Ana S. Mesa-Chavez, Fernanda Barrientos-Gutiérrez, Tonatiuh Tagliamento, Marco Lambertini, Matteo Villarreal-Garza, Cynthia

Immunogenicity and Risk of SARS-CoV-2 Infection after COVID-19 Vaccination in Patients with Cancer: A Systematic Review and Meta-Analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...